Recombinant Human SH2D1A (N-6His)

Description

EnkiLife provides the Recombinant Human SH2D1A (N-6His) protein,aslo know as SH2 Domain-Containing Protein 1A,Duncan Disease SH2-Protein,Signaling Lymphocytic Activation Molecule-Associated Protein,SLAM-Associated Protein,T-Cell Signal Transduction Molecule SAP,SH2D1A,DSHP,SAP, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human SH2 Domain-Containing Protein 1A is produced by our E.coli expression system and the target gene encoding Met1-Pro128 is expressed with a 6His tag at the N-terminus.Accession:O60880. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:16.4 KDa. Background:SH2 Domain-Containing Protein 1A,(SH2D1A) contains one SH2 domain and a short tail and is localized in the cytoplasm. SH2D1A is expressed at a high level in the thymus and the lung, with lower expression levels in the spleen and the liver. SH2D1A acts as an inhibitor of the signaling lymphocyte activation molecule (SLAM) self-association. In addition, SH2D1A mediates interaction between FYN and SLAMF1. It is also thought to regulate the activity of the neurotrophin receptors NTRK1, NTRK2 and NTRK3.